Multiple Sclerosis

The foveal avascular zone, or FAZ, area deteriorated at 12 months in eyes with stable laser-treated proliferative diabetic retinopathy and macular capillary nonperfusion, but vision loss was not common, according to a study.

The average wait time between a referral and neurologist visit was more than a month among older adults, with longer wait times for those with serious neurodegenerative conditions like MS, epilepsy and Parkinson’s disease, new research shows.

Greater access to community health centers may improve outcomes for Medicaid recipients and adults without insurance who have end-stage kidney disease, data show. Amid systematic barriers in health care, “nephrology is unique in that U.S. federal health insurance, Medicare, covers most patients with ESKD irrespective of age or income,” Yoshio N. Hall, MD, MS, academic professor of medicine in nephrology at the University of Washington Kidney Research Institute in Seattle, told Healio. “However, this near-universal coverage does not extend to patients with non-dialysis-dependent kidney disease. As such, most nephrology practices in the U.S. continue to focus their care on patients who require maintenance dialysis."

Healio Neurology looks back at the most popular Q&As with industry and specialty experts from the past year.

The FDA granted breakthrough therapy designation to an oral, investigational, brain-penetrant and bioactive Bruton’s tyrosine kinase inhibitor for adults with non-relapsing secondary progressive MS.

Catch up on Healio’s news in diabetic retinopathy for Diabetes Awareness Month.

Advancing equitable access to palliative care will require interdisciplinary collaboration and effective communication, according to several leaders in the field.

Top-line results of a phase 2 clinical trial for an adiposederived autologous mesenchymal stem cell therapy to address mild to moderate relapsing-remitting MS found the treatment improved mental and physical health at 52 weeks.

In pregnant women with MS given ocrelizumab, treatment did not result in infant B-cell depletion after birth, and the drug was virtually undetectable in the bloodstream of mother and child, according to a poster from ECTRIMS 2024.

SAN DIEGO — Researchers reported a sudden decrease in all-cause hospitalization at the beginning of the COVID-19 pandemic, but there was an increase in all-cause mortality in patients on maintenance dialysis.